Σύγκριση μεθόδων

	Βαθμολογία Wells για Εν τω Βάθει Φλεβική Θρόμβωση (ΕΒΦ)	Βαθμολογία CHA₂DS₂-VASc
Πεδίο	Κλινική Αξιολόγηση	Κλινική Αξιολόγηση
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	1994	2010
Δημιουργός	Philip S. Wells	Gregory Y. H. Lip, Robby Nieuwlaat, et al.
Τύπος	Venous thromboembolism risk stratification	Atrial fibrillation stroke risk stratification
Θεμελιώδης πηγή	Wells, P. S., Hirsh, J., Anderson, D. R., et al. (1994). A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography. Archives of Internal Medicine, 154(13), 1541-1546.	Lip, G. Y., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 137(2), 263-272.
Εναλλακτικές ονομασίες	Wells DVT Score, DVT Wells	CHA2DS2VASc, Atrial fibrillation stroke risk
Συναφείς	3	3
Σύνοψη	The Wells score, developed by Wells et al. in 1994, is a clinical prediction rule that stratifies patients into low, intermediate, or high pretest probability of deep vein thrombosis (DVT). It combines seven clinical features to guide diagnostic testing decisions and reduce unnecessary imaging in suspected DVT patients.	The CHA₂DS₂-VASc score, developed by Lip, Nieuwlaat, and colleagues in 2010, is a 9-point risk stratification tool for predicting annual stroke and systemic thromboembolism risk in patients with atrial fibrillation. It is the recommended score by major cardiology guidelines for guiding anticoagulation decisions.